cardiovascular

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Braveheart Bio launches with $185M Series A

Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kardigan $254m Series B

Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…

by Timos Papagatsias

mHealth H1 2025

Trending in Health Mobile Apps H1 2025

📊 Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H1…

by LucidQuest

Digital health apps for cardiovascular disease

Watch out for your heart! Digital health apps to improve cardiovascular disease care.

Cardiovascular disease is a leading cause of death worldwide; the WHO estimated…

by Akshay Baviskar

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.